Brief: SyntheticMR Gains Further Clearance From FDA For Its Software SyMRI
June 13 (Reuters) - SYNTHETICMR AB (PUBL) SYNTH.TE :
* SAID ON TUESDAY CO HAD GAINED FURTHER CLEARANCE FROM FDA
FOR ITS
SOFTWARE SYMRI
* SAID CLEARANCE CONCERNED THE CLINICAL USE OF SYMRI
TOGETHER WITH
PHILIPS MR SCANNERS
Source text for Eikon: urn:newsml:reuters.com:*:nWkr5PXT9M
Further company coverage: SYNTH.TE
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SyntheticMR AB
See all newsSweden's SyntheticMR Q2 sales rise, loss narrows on cNeuro strength, India growth
Brief: SyntheticMR Q2 Operating Profit SEK -6.5 Million
SyntheticMR Q1 net sales fall 8% on lower OEM sales in Europe, North America
Brief: SyntheticMR Q1 Operating Profit SEK -6.3 Million
Sweden's SyntheticMR Q4 sales rise 42% yr/yr